Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Key Movement
    • Bayer CropScience...

    Bayer CropScience appoints Pankaj Patel as Chairman

    Written by savita thakur thakur Published On 2016-07-07T15:07:18+05:30  |  Updated On 7 July 2016 3:07 PM IST
    Bayer CropScience appoints Pankaj Patel as Chairman

    New Delhi : Bayer CropScience appointed Pankaj Patel as non-executive director and chairman of the company following beleaguered businessman Vijay Mallya's resignation last month.


    In a filing to the BSE, Bayer CropScience informed that the board, in its meeting held, appointed Pankaj Patel as an additional non-executive director of the company with effect from July 5.


    "The Board further appointed Pankaj Patel as the Chairman of the Board with effect from July 5, 2016 to chair all the meetings of the Board of Directors and the General Meetings of the company," it added.


    Last month, Mallya had resigned as the Chairman of Bayer CropScience Ltd after over 12 years of holding the position in the company. Mallya ceased to be the Chairman and Director with effect from June 30.


    Pankaj Patel is the Chairman and Managing Director of Zydus Cadila, one of India's leading pharmaceutical groups and an innovation-driven, global healthcare firm with operations in more than 50 countries worldwide, Bayer CropScience said in a statement.


    With an experience spanning over 40 years in the Indian pharmaceutical industry, Patel combines both research and techno-commercial expertise.


    Patel is also the Chairman of Bayer Zydus Pharma Pvt Ltd a joint venture company between Bayer (South East Asia) Pte Ltd and Cadila Healthcare Ltd.


    Bayer is a global enterprise with core competencies in life science fields of healthcare and agriculture. In India, Bayer CropScience is into seed and crop protection business.

    Bayer CropScienceCadila HealthcareHealthcarePankaj PatelVijay Mallya'sZydus Pharmaceuticals
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok